Greenhouse Funds’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Hold
115,800
0.09% 32
2026
Q1
$859K Buy
+115,800
New +$1.22M 0.04% 33
2023
Q4
Sell
-250,000
Closed -$3.08M 40
2023
Q3
$3.08M Buy
+250,000
New +$3.72M 0.23% 37

Other funds holding NEO

Greenhouse Funds's NEO Position: Q2 2026 in Review

Greenhouse Funds reduced its NeoGenomics (NEO) stake by 5.8% in Q2 2026, selling an estimated $5.07M and leaving 8,574,210 shares worth $125M. The position accounts for 6.39% of the portfolio, ranked #3.

Greenhouse Funds first reported a position in NEO in Q1 2022 and has held it in 18 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Greenhouse Funds held 8,574,210 shares of NeoGenomics worth $125M as of Q2 2026.
  • Greenhouse Funds sold 525,893 NeoGenomics shares in Q2 2026, an estimated $5.07M.
  • NeoGenomics made up 6.39% of Greenhouse Funds's portfolio in Q2 2026, its #3 holding.
  • Greenhouse Funds first reported a position in NeoGenomics in Q1 2022 and has held it in 18 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Greenhouse Funds's 13F filing for Q2 2026, filed 14 Aug 2026.